0001374339-22-000002.txt : 20221021 0001374339-22-000002.hdr.sgml : 20221021 20221021140920 ACCESSION NUMBER: 0001374339-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221021 DATE AS OF CHANGE: 20221021 EFFECTIVENESS DATE: 20221021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462506 FILM NUMBER: 221323064 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D 1 primary_doc.xml X0708 D LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 416-817-6898 CANADA (FEDERAL LEVEL) 4203801 Canada Inc. AMORFIX LIFE SCIENCES LTD Corporation true Gail M. Farfel 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Neil Cashman 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Larry Altstiel 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Gavin T. Malenfant 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Daniel Geffken 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Eugene Williams 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director Richard Gregory 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director Patrick Kirwin 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director Josh Mandel-Brehm 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director Maggie Shafmaster 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director Neil K. Warma 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director William Wyman 1920 Yonge Street Suite 200 Toronto A6 ONTARIO, CANADA M4S 3E2 Director Biotechnology No Revenues 06b false 2022-10-11 true true true true true Each unit consists of one common share and one-quarter of one common share purchase warrant. Each full warrant is exercisable for one common share at an exercise price of $7.50 per common share starting April 11, 2023 until April 11, 2028. false 27000 CEROS FINANCIAL SERVICES, INC. 37869 None None 1445 RESEARCH BOULEVARD SUITE 530 ROCKVILLE MD MARYLAND 20850 CA CALIFORNIA CO COLORADO FL FLORIDA IL ILLINOIS MA MASSACHUSETTS NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK TX TEXAS VT VERMONT VA VIRGINIA false 10066823 7472282 2594541 The additional $2,594,541.00 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. false 23 597783 true 0 Compensation also includes warrants to purchase 69,188 common shares at $6.10 per share exercisable April 11, 2023 until April 11, 2028, and legal fees of $80,000. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false ProMIS Neurosciences Inc. Gail M. Farfel Gail M. Farfel Chief Executive Officer 2022-10-20